Professor Lixin Xie, a member of the Chinese Academy of Engineering, led a dry eye treatment study at the Qingdao Eye Hospital. The treatment, known as HBM9036, was led by a Chinese sponsor known as Harbour Biomed—a partner to Korean venture HanAll Biopharma. The...